The Evolving Psychopharmacology Of Major Depressive Disorder: Narrowing The Treatment Gap
Archived Webinar | July 23, 2015
Not a member? Sign up for free!
Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration. Sign up today for instant access to all PsychU offerings. Membership is free!
Depression is a widespread condition estimated to affect millions of adults in the United States alone. Despite the significant burden associated with depression, only a fraction of patients are estimated to receive minimally adequate treatment. While there are a number of treatment options and guidelines for treatment strategies exist, depression continues to constitute a significant…
PsychU offers private, personalized educational programs, both online and in-person, on a range of topics, including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and health care policy.
Any PsychU member can request a presentation for their region or organization for free.
This link will take you outside of the PsychU community website.
By selecting continue, you will be leaving PsychU. The destination site to which you will be redirected is not controlled or endorsed by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and / or Lundbeck, LLC.